MedTrace Logo

The Colonic Microbiome and Mucosal Immunity in Inflammatory Bowel Disease and Ankylosing Spondylitis

NCT02389075 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 129

Last updated 2024-05-21

No results posted yet for this study

Summary

This study plans to learn more about the relationship between systemic autoimmune disease, such as inflammatory bowel disease and ankylosing spondyloarthritis, bacteria in the colon, and the changes in colon tissue.

Conditions

  • Inflammatory Bowel Diseases (IBD)
  • Ankylosing Spondylitis (AS)

Interventions

PROCEDURE

Pinch biopsies

Biopsies obtained during colonoscopy or flexible sigmoidoscopy.

PROCEDURE

Flexible sigmoidoscopy

Offered to subjects with ankylosing spondylitis who do not meet criteria for colonoscopy

Sponsors & Collaborators

  • National Center for Advancing Translational Sciences (NCATS)

    collaborator NIH

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Kristie Kuhn, MD, PhD · University of Colorado, Denver

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2026-10-31
Completion
2026-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02389075 on ClinicalTrials.gov